Kevin Flanagan

Kevin Flanagan has a diverse work experience spanning over several companies and roles. Kevin is currently serving as the Director of Pharmacovigilance Compliance at Novavax Inc, a position they have held since February 2021. Prior to that, they worked at Intercept Pharmaceuticals as the Associate Director of MSPV Compliance, PV Agreements, Training & QPPV Office from December 2018 to February 2021. Kevin also has experience working as a Senior Quality Assurance Manager at Celgene from May 2017 to November 2018, and as a Senior Safety System Analyst at Allergan from January 2015 to May 2017. Before that, Kevin held positions at Forest Laboratories as the Associate Director of Safety Alliance Management from an unspecified time to April 2014, as well as at Novartis in various roles such as Associate Director of Legal Data Services from an unspecified time to an unspecified time, US Head of Safety Data Management from 2001 to 2007, and Senior Technical Information Specialist from 1998 to 2001. Kevin also briefly worked as a Marketing Communication Manager at Novartis in 1997. Throughout their career, Kevin has demonstrated expertise in compliance, quality assurance, safety management, and data management, among other areas.

Kevin Flanagan completed their Bachelor of Arts degree in Psychology at Caldwell University in 1998. In 1999-2000, they pursued a Master of Library Science degree with a focus on Information Structures and Systems at Rutgers University.